Trial · NCT01570504
Multiple Versus Single Dose of Ivermectin for the Treatment of Strongyloidiasis
NCT01570504, Phase 3, Completed, Centro per le Malattie Tropicali
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Multiple Versus Single Dose of Ivermectin for the Treatment of Strongyloidiasis. Trials, record NCT01570504. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT01570504
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Multiple Versus Single Dose of Ivermectin for the Treatment of Strongyloidiasis
- NCT number
- NCT01570504
- Status
- Completed
- Phases
- Phase 3
- Enrollment
- 312 participants, actual
- Lead sponsor
- Centro per le Malattie Tropicali
- Conditions
- Strongyloidiasis
- Interventions
- Ivermectin
- First posted
- 2012-04-04
- Last updated
- 2018-06-14
- Other registries' IDs
- eudract:2011-002784-24
Source ClinicalTrials.gov
Registered outcomes8
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | clearance of strongyloides infection | 12 months | Clearance of infection is defined by: negative stool agar/charcoal culture/RT-PCR - direct examination of three faecal samples for S. stercoralis AND negative serology or decrease in titer below a defined cutoff |
| Secondary | All-cause mortality during the 12 months of follow-up. | 12 months | |
| Secondary | Patients with partial response to treatment at T 2 | 12 months | |
| Secondary | Patients with adverse reactions | From Day 1st to Day 5th of treatment and from Day 15th to Day 19th (or 72 hours from treatment completion) | grade 1 to 5 as defined in detailed protocol |
| Secondary | Patients with increase in blood ALT over cutoff value | Day 17 | |
| Secondary | Patients with decrease in WBC count below cutoff value | Day 17 | |
| Secondary | Average difference in blood ALT and WBC count at day 17, compared with baseline | Day 17 | |
| Secondary | Average difference in blood eosinophil count at T2, compared with baseline | 12 months |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers1
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as |
|---|---|
| 31558376 | DERIVED |
Source PubMed
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT01570504
GET https://conductscience.org/api/trials/v1/NCT01570504/registered